Adrenal Cancer

+ -Text Size

Early Detection, Diagnosis, and Staging TOPICS

Survival rates by stage for adrenal cancer

Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with cancer want to know the survival statistics for people in similar situations, while others might not find the numbers helpful, or not want to know them. If you decide you don’t want to know them, stop reading here and skip to the next section.

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured).

Five-year relative survival rates assume that some people will die of other causes and compare the observed survival with that expected for people without the cancer. This is a better way to see the impact of the cancer on survival.

In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with adrenal cortical cancer.

Survival rates are often based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person's case. Many other factors besides stage can affect a person's outlook, such as the grade of their cancer, the treatment they receive, their age, and overall health. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your particular situation.

The numbers below come from the National Cancer Institute's SEER database, and are based on people diagnosed between 1988 and 2001. The SEER database does not list survival statistics by AJCC or ENSAT stages. Instead, it divides patients into 3 groups: localized, regional, and distant. Localized means that the cancer hasn't grown outside of the adrenal gland at diagnosis (like stages I and II). Regional means that the cancer has grown into nearby tissues or has spread to nearby lymph nodes (like ENSAT stage III). Distant means that the cancer has spread further to distant sites (like ENSAT stage IV).

    Stage

    5-year
    Relative Survival

    Localized

    65%

    Regional

    44%

    Distant

    7%


Last Medical Review: 03/19/2014
Last Revised: 04/10/2014